|
MechanismHistamine receptor modulators [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date31 Dec 1987 |
100 Clinical Results associated with ECR Pharmaceuticals Co., Inc.
0 Patents (Medical) associated with ECR Pharmaceuticals Co., Inc.
100 Deals associated with ECR Pharmaceuticals Co., Inc.
100 Translational Medicine associated with ECR Pharmaceuticals Co., Inc.